Corpus overview


MeSH Disease

HGNC Genes

SARS-CoV-2 proteins

There are no SARS-CoV-2 protein terms in the subcorpus


SARS-CoV-2 Proteins
    displaying 1 - 2 records in total 2
    records per page

    Clinical evolution of COVID-19 MESHD during pregnancy at different altitudes: a population-based study

    Authors: Juan Alonso Leon-Abarca; Maria Teresa Pena-Gallardo; Jorge Soliz; Roberto Alfonso Accinelli

    doi:10.1101/2020.09.14.20193177 Date: 2020-09-18 Source: medRxiv

    Background: The impact of influenza and various types of coronaviruses ( SARS-CoV and MERS-CoV MESHD) on pregnancy has been reported. However, the current pandemic caused by SARS-CoV-2 continues to reveal important data for understanding its behavior in pregnant women. Methods: We analyzed the records of 326,586 non-pregnant women of reproductive age and 7,444 pregnant women with no other risk factor who also had a SARS-CoV-2 RT-PCR result to estimate adjusted prevalence (aP) and adjusted prevalence ratios ( aPR HGNC) of COVID-19 MESHD and its requirement of hospitalization, intubation, ICU admission and case-fatality rates. Adjustment was done through Poisson regressions for age and altitude of residence and birth. Generalized binomial models were used to generate probability plots to display how each outcome varied across ages and altitudes. Results: Pregnancy was independently associated with a 15% higher probability of COVID-19 MESHD ( aPR HGNC: 1.15), a 116% higher probability of its following admission ( aPR HGNC: 2.169) and a 127% higher probability of ICU admission ( aPR HGNC: 2.275). Also, pregnancy was associated with 84.2% higher probability of developing pneumonia MESHD ( aPR HGNC: 1.842) and a 163% higher probability of its following admission ( aPR HGNC: 2.639). There were no significant differences in COVID-19 MESHD case-fatality rates between pregnant and non pregnant women (1.178, 95% CI: 0.68-1.67). Conclusion: Pregnancy was associated with a higher probability of COVID-19 MESHD, developing of pneumonia MESHD, hospitalization, and ICU admission. Our results also suggest that the risk of COVID-19 MESHD and its related outcomes, except for intubation, decrease with altitude. Keywords: COVID-19 MESHD, SARS-CoV-2, pregnancy, reproductive age, altitude

    Age-dependent regulation of SARS-CoV-2 cell entry genes and cell death programs correlates with COVID-19 MESHD disease severity

    Authors: Zintis Inde; Clarence Yapp; Gaurav N Joshi; Johan Spetz; Cameron Fraser; Brian Deskin; Elisa Ghelfi; Chhinder Sodhi; David Hackam; Lester Kobzik; Ben Croker; Douglas Brownfield; Hongpeng Jia; Kristopher A. Sarosiek; Paige D. Hall; Maud Jansen; Kumaran Shanmugarajah; Jessica S. Donington; Florian Krammer; Daved Fremont; Andrzej Joachimiak; Yoshihiro Kawaoka; Vera Tesic; Maria Lucia Madariaga; Patrick C Wilson; Martin Pettersson; Mattew R. Reese; Thomas Rogers; Michelle I Rossulek; Jean G Sathish; Claire Steppan; Martyn Ticehurst; Lawrence W. Updyke; Yuao Zhu; Jun Wang; Arnab K Chatterjee; Andrew D Mesecar; Annaliesa S. Anderson; Charlotte Allerton

    doi:10.1101/2020.09.13.276923 Date: 2020-09-13 Source: bioRxiv

    Angiotensin-converting enzyme 2 ( ACE2 HGNC) maintains cardiovascular and renal homeostasis MESHD but also serves as the entry receptor for the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) MESHD, the causal agent of novel coronavirus disease 2019 MESHD ( COVID-19 MESHD)1. COVID-19 MESHD disease severity, while highly variable, is typically lower in pediatric patients than adults (particularly the elderly), but increased rates of hospitalizations requiring intensive care are observed in infants than in older children. The reasons for these differences are unknown. To detect potential age-based correlates of disease severity, we measured ACE2 HGNC protein expression at the single cell level in human lung tissue specimens from over 100 donors from [~]4 months to 75 years of age. We found that expression of ACE2 HGNC in distal lung epithelial cells generally increases with advancing age but exhibits extreme intra- and inter-individual heterogeneity. Notably, we also detected ACE2 HGNC expression on neonatal airway epithelial cells and within the lung parenchyma. Similar patterns were found at the transcript level: ACE2 HGNC mRNA is expressed in the lung and trachea shortly after birth, downregulated during childhood, and again expressed at high levels in late adulthood in alveolar epithelial MESHD cells. Furthermore, we find that apoptosis, which is a natural host defense system against viral infection MESHD, is also dynamically regulated during lung maturation, resulting in periods of heightened apoptotic priming and dependence on pro-survival BCL-2 family proteins including MCL-1 HGNC. Infection of human lung cells with SARS-CoV-2 triggers an unfolded protein stress response and upregulation of the endogenous MCL-1 HGNC inhibitor Noxa HGNC; in juveniles, MCL-1 HGNC inhibition is sufficient to trigger apoptosis in lung epithelial cells - this may limit virion production and inflammatory signaling. Overall, we identify strong and distinct correlates of COVID-19 MESHD disease severity across lifespan and advance our understanding of the regulation of ACE2 HGNC and cell death programs in the mammalian lung. Furthermore, our work provides the framework for potential translation of apoptosis modulating drugs as novel treatments for COVID-19 MESHD.

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from and is updated on a daily basis (7am CET/CEST).
The web page can also be accessed via API.



MeSH Disease
HGNC Genes
SARS-CoV-2 Proteins

Export subcorpus as...

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.